Zinc(II) enhances radical scavenging of the flavonoid kaempferol (Kaem) most significantly for the 1:1 Zn(II)-Kaem complex in equilibrium with the 1:2 Zn(II)-Kaem complex both with high affinity at 3-hydroxyl and 4carboxyl coordination. In methanol/chloroform (7/3, v/v), 1:1 Zn(II)-Kaem complex reduces β-carotene radical cation, β-Car •+ , with a second-order rate constant, 1.88 × 10 8 L• mol −1 •s −1 , while both Kaem and 1:2 Zn(II)-Kaem complex are nonreactive, as determined by laser flash photolysis. In ethanol, 1:1 Zn(II)-Kaem complex reduces the 2,2-diphenyl-1-picrylhydrazyl radical, DPPH • , with a second-order rate constant, 2.48 × 10 4 L•mol −1 •s −1 , 16 times and 2 times as efficient as Kaem and 1:2 Zn(II)-Kaem complex, respectively, as determined by stopped-flow spectroscopy. Density functional theory calculation results indicate significantly increased acidity of Kaem as ligand in 1:1 Zn(II)-Kaem complex other than in 1:2 Zn(II)-Kaem complex. Kaem in 1:1 Zn(II)-Kaem complex loses two protons (one from 3-hydroxyl and one from phenolic hydroxyl) forming 1:1 Zn(II)-(Kaem−2H) during binding with Zn(II), while Kaem in 1:2 Zn(II)-Kaem complex loses one proton in each ligand forming Zn(II)-(Kaem−H) 2 , as confirmed by UV−vis absorption spectroscopy. Zn(II)-(Kaem−2H) is a far stronger reductant than Kaem and Zn(II)-(Kaem−H) 2 as determined by cyclic voltammetry. Significant rate increases for the 1:1 complex in both β-Car •+ scavenging by electron transfer and DPPH • scavenging by hydrogen atom transfer were ascribed to decreases of ionization potential and of bond dissociation energy of 4′-OH for deprotonated Zn(II)-(Kaem−2H), respectively. Increased phenol acidity of plant polyphenols by 1:1 coordination with Zn(II) may explain the unique function of Zn(II) as a biological antioxidant and may help to design nontoxic metal-based drugs derived from natural bioactive molecules.
Luteolin differs as a radical scavenger dramatically
from apigenin in response to Cu(II) coordination despite a minor structural
difference. Coordination of Cu(II) increases the radical scavenging
efficiency of luteolin, especially at low pH, while decreases the
efficiency of apigenin at both low and higher pH as studied by ABTS•+ radical scavenging. Luteolin forms a 1:1 complex
with Cu(II) binding to 4-carbonyl and 5-phenol for pH <6 and to
3′,4′-catechol for pH >6. Apigenin forms a 1:2 complex
independent of pH coordinated to 4-carbonyl and 5-hydroxylyl. Cu(II)
coordinated to luteolin, as studied by pH jump stopped-flow, translocates
with rate constants of 11.1 ± 0.3 s–1 from
4,5 to 3′,4′ sites and 1.0 ± 0.1 s–1 from 3′,4′ to 4,5 sites independent of Cu(II) concentration,
pointing toward the dissociation of Cu(II) from an intermediate with
two Cu(II) coordination as rate determining. 3′,4′-Catechol
is suggested to be a switch for Cu(II) translocation with deprotonation
initiating 4,5 to 3′,4′ translocation and protonation
initiating 3′,4′ to 4,5 translocation. For dicoordinated
apigenin, the coordination symmetry balances an electron withdrawal
effect of Cu(II) resulting in a decrease of phenol acidity and less
radical scavenging efficiency compared to parent apigenin. Compared
to that of parent luteolin, the radical scavenging rate of both 4,5
and 3′,4′ Cu(II)-coordinated luteolin is enhanced through
increased phenol acidity by electron withdrawal by Cu(II), as confirmed
by density functional theory (DFT) calculations. Coordination and
translocation of Cu(II) accordingly increases the antioxidant activity
of luteolin at pH approaching the physiological level and is discovered
as a novel class of natural molecular machinery derived from plant
polyphenols, which seems to be of importance for protection against
oxidative stress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.